Takeda

Analysis of Takeda’s prescription pharmaceutical sales encompassing global corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2014–24.

Shionogi Company Analysis

Updated analysis and forecasts based on 2016 company-reported sales.

Pharmavitae Analytics explores Shionogi’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2016–26.

Daiichi Sankyo Company Analysis

PharmaVitae explores Daiichi Sankyo’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2016–26.